Human Vaccines & Immunotherapeutics Sign in to save
Aachen papers per year
Papers 11
-
Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries2021 Human Vaccines & Immunotherapeutics article Medicine Viral gastroenteritis research and epidemiology Open access
Prashant Kumar, Ashaben Patel, Swathi R. Pullagurla, Oluwadara Ogun, Ozan S. Kumru, Ahd Hamidi, +5 more
13citations -
Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial2024 Human Vaccines & Immunotherapeutics article Medicine Viral Infections and Outbreaks Research Open access cited by 2 patents
Neil H. Goldstein, Chelsea M. McLean, Auguste Gaddah, Joachim Doua, Babajide Keshinro, Linda Bus-Jacobs, +4 more
8citations -
Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: a phase 1 randomized controlled trial in adults2020 Human Vaccines & Immunotherapeutics article Medicine Viral Infections and Immunology Research Open access
Isabel Leroux‐Roels, Geert G Leroux-Roels, Georgi Shukarev, Hanneke Schuitemaker, Conor P. Cahill, Richard de Rooij, +3 more
8citations -
Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age2022 Human Vaccines & Immunotherapeutics article Medicine Viral Infections and Immunology Research Open access
Anna Lisa Ong‐Lim, Georgi Shukarev, Mitzi Trinidad‐Aseron, Delia Caparas-Yu, Astrid E. Greijer, Michel Duchêne, +7 more
4citations -
Immunogenicity and safety of Ad26.RSV.preF/RSV preF protein vaccine at predicted intermediate- and end-of-shelf-life as an evaluation of potency throughout shelf life2024 Human Vaccines & Immunotherapeutics article Medicine Respiratory viral infections research Open access
Tessa Hosman, Roy van Heesbeen, Arangassery Rosemary Bastian, Christy A. Comeaux, Nynke Ligtenberg, Bart van Montfort, +2 more
4citations -
T-cell responses to SARS-CoV-2 vaccinations in adults with Down syndrome – a prospective cohort study2025 Human Vaccines & Immunotherapeutics article Medicine SARS-CoV-2 and COVID-19 Research Open access
Lobke C.M. Hensen, Bianca M. M. Streng, Femke van Wijk, Stefan Nierkens, Rob S. van Binnendijk, Anne‐Marie Buisman, +14 more
3citations -
Immunogenicity, safety and reactogenicity of Ad26.RSV.preF/RSV preF protein vaccine in adults aged 60 to 75 years: A comparison of phase 2b and phase 3 clinical trial material2024 Human Vaccines & Immunotherapeutics article Medicine Respiratory viral infections research Open access
Archana M. Jastorff, Arangassery Rosemary Bastian, Nynke Ligtenberg, V. G. Klyashtorny, Benoît Callendret, Esther Heijnen
3citations -
Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial2025 Human Vaccines & Immunotherapeutics article Medicine SARS-CoV-2 and COVID-19 Research Open access
Jelena Tica, Veronica V. Rezelj, Benoît Baron, Vitalija van Paassen, Javier Zaidman, Lee Fairlie, +16 more
3citations -
Pneumococcal vaccine hyporesponsiveness in people living with HIV: A narrative review of immunological mechanisms and insights from minimally invasive lymph node sampling2025 Human Vaccines & Immunotherapeutics review Medicine Pneumonia and Respiratory Infections Open access
Giovanni E. Loe-Sack-Sioe, Leo G. Visser, Simon P. Jochems, Anna H.E. Roukens
1citations -
T-cell responses to primary SARS-CoV-2 vaccination in Down syndrome – From childhood to adulthood2026 Human Vaccines & Immunotherapeutics article Medicine SARS-CoV-2 and COVID-19 Research Open access
Lobke C.M. Hensen, Bianca M. M. Streng, Femke van Wijk, Stefan Nierkens, Joanne Wildenbeest, Louis Bont, +16 more
0citations -
Repurposing licensed viral vaccines as anti-cancer therapeutics: Turning cold tumors hot2026 Human Vaccines & Immunotherapeutics article Biochemistry, Genetics and Molecular Biology Virus-based gene therapy research Open access
Dorine A. De Bont, Maud Reugebrink, Nadine van Montfoort, Vera Kemp
0citations
11 results
Most active Aachen authors
-
Macaya Douoguih 8,403 citations overall3 papers
-
Hanneke Schuitemaker 31,102 citations overall2 papers
-
Gert C. Scheper 9,874 citations overall2 papers
-
Mathieu Le Gars 6,201 citations overall2 papers
-
Benoît Callendret 3,320 citations overall2 papers
-
Esther Heijnen 3,046 citations overall2 papers
-
Michel Emile Weijerman 1,884 citations overall2 papers
-
Jeanne‐Marie Jacquet 1,672 citations overall2 papers
-
Arangassery Rosemary Bastian 997 citations overall2 papers
-
Vitalija van Paassen 24 citations overall2 papers
-
Nynke Ligtenberg 22 citations overall2 papers
-
Veronica V. Rezelj 8,782 citations overall1 paper
-
Leo G. Visser 8,259 citations overall1 paper
-
Jenny Hendriks 6,518 citations overall1 paper
-
Kerstin Lühn 3,481 citations overall1 paper